Calcifediol (25-Hydroxyvitamin D3) from Japan
Calcifediol is the 25-hydroxylated active metabolite of Vitamin D3, used primarily as a vitamin derivative in therapeutic supplements. It qualifies for HTS 2936.29.50.20 as a Vitamin D derivative that is a separate chemically defined organic compound essential for treating vitamin D deficiency. Supplied in high-purity crystalline form for pharmaceutical compounding.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include stability data showing no degradation during transport, as required for vitamin derivatives
• FDA prior notice required; file through ACE system 72 hours before arrival for dietary ingredients